Internal Medicine, Infectious Disease · Columbia, SC
NPI
1386612976
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1 Richland Medical Park Dr Ste 410420
Columbia, SC, 29203
Phone (803) 545-5350
Medicare paid, 2024
$29K
1,144 services
Medicare patients, 2024
173
Average age 72
Drug cost, 2024
$4.4M
2,462 prescriptions
Company payments, 2025
$47.67
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph A Horvath was code 36415 (venipuncture blood collection), 140 times for 58 patients. In total Joseph A Horvath billed 1,144 services in 29 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 140 | 58 | $8.65 | $1,211 |
| 99214 Office E&M - Established | Office | 106 | 77 | $91.41 | $9,689 |
| 99204 Office E&M - New | Office | 49 | 49 | $124.15 | $6,083 |
| 99213 Office E&M - Established | Office | 24 | 24 | $49.02 | $1,177 |
| 99223 Hospital E&M - Initial | Facility | 22 | 22 | $133.60 | $2,939 |
| 99222 Hospital E&M - Initial | Facility | 13 | 13 | $97.88 | $1,272 |
By year: 2022 $27K for 548 services; 2023 $37K for 940 services; 2024 $29K for 1,144 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 140 | 58 | $8.65 | $1,211 |
Medicare prescription drug claims, 2024
In 2024, the drug Joseph A Horvath prescribed most often to Medicare patients was Genvoya (Elviteg/Cob/Emtri/Tenof Alafen), with 325 prescriptions and refills. In total Joseph A Horvath wrote 2,462 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 325 | 333 | 29 | $1.3M |
| Descovy Emtricitabine/Tenofov Alafenam | 157 | 157 | 17 | $336K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 152 | 152 | 21 | $588K |
| Tivicay Dolutegravir Sodium | 146 | 146 | 15 | $319K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 124 | 132 | 13 | $491K |
| Atorvastatin Calcium Generic | 90 | 106 | Under 11 | $406 |
| Imipenem-Cilastatin Sodium Imipenem/Cilastatin Sodium | 77 | 77 | Under 11 | $23K |
| Amlodipine Besylate Generic | 70 | 70 | Under 11 | $239 |
| Azithromycin Generic | 63 | 70 | 17 | $1,614 |
| Daptomycin Generic | 49 | 49 | Under 11 | $29K |
| Amikacin Sulfate Generic | 40 | 40 | Under 11 | $2,786 |
| Isentress Raltegravir Potassium | 37 | 37 | Under 11 | $73K |
| Ertapenem Ertapenem Sodium | 34 | 34 | Under 11 | $25K |
| Prezcobix Darunavir/Cobicistat | 32 | 32 | Under 11 | $76K |
| Valacyclovir Valacyclovir Hcl | 31 | 33 | Under 11 | $1,172 |
Brand drugs: 1,236 claims; generic drugs: 1,226 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph A Horvath $47.67 ($47.67 in general payments such as food, travel and fees) from 1 company. The largest payer was Otsuka America Pharmaceutical, Inc. with $47.67.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $47.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.